FOR REFERRING CLINICIANS

A comprehensive workup for patients who've exhausted the standard options.

AMI manages acute migraine care and medications while building a continuous, multi-domain picture of each patient: metabolic, autonomic, hormonal, sleep, cervical, cognitive and psychological. Treatment is matched to the contributors we find. We work alongside you, not in place of you, and our methods are grounded in our own published phenotype research.

Refer a patient Read the published research

WHO TO REFER

Good candidates

  • Adults with chronic migraine
  • Inadequate response to standard preventive therapy
  • Motivated to take part in home monitoring and a structured, months-long plan

WHAT YOU GET BACK

A partner, with data

  • Intake summary and a workup report across every domain we tested
  • Regular progress updates: migraine frequency, medication use and continuous-data trends
  • Medication changes coordinated with the prescribing clinician
  • Your patient returns to you for ongoing care

THE WORKUP

An in-depth core workup for every patient. Greater depth where it's indicated.

Most evaluations start with a visit and a few labs. Every AMI patient starts with weeks of continuous, real-world data across every domain. Advanced testing then goes deeper in any domain where the core workup points to it, and only there: no sleep study without signs of disordered sleep, no hormone panel without a hormonal pattern. Red flags go to imaging and referral first.

CORE WORKUP · EVERY PATIENT

History & medications

Comprehensive headache and medication history, records review, interaction review

Metabolic

CGM with variability metrics (MAGE, CONGA, postprandial AUC), complete dietary analysis, A1c, fasting glucose and insulin

Autonomic

Continuous wearable heart rate and HRV

Sleep & activity

Wearable sleep analysis, exercise patterns, daily schedule

Neurocognitive

Neurocognitive assessment

Psychological

Depression, anxiety and attention screens

Hormonal

Screened through history: menstrual, contraceptive and menopausal pattern, endocrine symptoms

Cervical spine

Screened through history and physical examination of the neck

General health

Baseline labs, including inflammation markers

ADVANCED TESTING, WHEN THE CORE WORKUP POINTS TO IT

Medication

Pharmacogenomics, medication-overuse assessment

When: polypharmacy, poor response or intolerance, frequent rescue use

Metabolic

Oral glucose tolerance test with serial insulin, for glycemic phenotyping

When: CGM or labs show dysregulation

Autonomic

Extended monitoring: temperature, respiration, SpO₂

When: HR or HRV suggests autonomic dysregulation

Hormonal

Estradiol, progesterone, testosterone, cortisol, thyroid panel

When: menstrual, contraceptive or perimenopausal pattern; endocrine symptoms

Sleep

Home sleep study

When: wearable data or history suggests disordered breathing or poor sleep quality

Cervical spine

Flexion/extension X-rays with motion analysis, posture and muscle assessment

When: neck pain, cervicogenic features, prior head or neck injury

Neurocognitive

Full neuropsychological evaluation, EEG

When: the core assessment flags deficits, or prior head trauma

Psychological

Full evaluation (HAM-A, ADHD, Big Five)

When: a positive core screen

Imaging

CT, MRI or MRA

When: red flags, such as a sudden severe headache or a new neurological sign

Most patients have advanced testing in several domains and more than one out of range. The treatment plan addresses each of those in one coordinated plan.

THE EVIDENCE

Glycemic phenotyping in chronic migraine.

Postprandial dysregulation

Chronic migraine subjects showed postprandial glucose dysregulation and greater glycemic variability than healthy controls.

Three GTT phenotypes

Clustering of glucose tolerance tests identified three distinct glucose and insulin response profiles.

The responder profile

Rising fasting insulin with normal fasting glucose; a steep postprandial rise (hepatic insulin resistance) and steep fall (peripheral and CNS insulin hypersensitivity). Ideal fasting insulin: roughly 2–8 µIU/mL.

Nelson CA, Reavely KW, Jennings MR, Burger BJ, Kim AC, Sant DW, Bills KB. Glucose dysregulation and glycemic phenotyping in chronic migraine. Front Neurol. 2026. doi:10.3389/fneur.2025.1719724

Our neuropsychological, electrophysiological and orthopedic phenotype work →

REFER A PATIENT

Three steps.

  1. 1Send the referral. Use the referral form, or call us. We'll request records through a secure channel.
  2. 2We contact your patient within 1 business day to schedule a consultation.
  3. 3You receive the workup report and proposed plan once testing and initial monitoring are complete.

Referral line: (801) 658-4564 · [email protected]

REFERRAL FORM

Call or email us to refer a patient.

Our secure online referral form is on its way. Until then, our team takes referrals by phone and email. Please don't include patient details in email; we'll call you back to collect them.

Call (801) 658-4564 Email the referral team

EDUCATION

Invite our clinicians to speak.

AMI clinicians present on the metabolic and multi-system drivers of chronic migraine for grand rounds, practice teams and professional meetings.

Request a talk